Recent Market Performance and Price Movement
On 18 Dec 2025, Entero Healthcare Solutions recorded a day decline of 1.38%, underperforming the Sensex which moved down by 0.20%. This marks the third consecutive day of losses for the stock, accumulating a negative return of 2.65% over this short span. The stock's performance over longer periods further illustrates the downward trend: a 1-week return of -3.49% compared with the Sensex's -0.50%, a 1-month return of -14.37% against the Sensex's -0.33%, and a 3-month return of -15.70% while the Sensex gained 1.66%.
Over the past year, Entero Healthcare Solutions has recorded a return of -33.83%, contrasting with the Sensex's positive 5.25%. Year-to-date figures also show a decline of 31.17% for the stock, whereas the Sensex has advanced by 8.00%. Notably, the stock has not registered any gains over the last three, five, and ten years, remaining flat at 0.00%, while the Sensex has appreciated by 37.58%, 79.71%, and 230.70% respectively over these periods.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish momentum.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
See What's Driving the Rally →
Comparative Sector and Market Context
Within the Retailing sector, Entero Healthcare Solutions has underperformed its peers and the broader market indices. The sector itself has shown mixed results, but the stock's relative weakness is evident when compared to the BSE500 index and Sensex benchmarks. The stock's 3-year and 1-year returns lag behind these indices, highlighting a divergence from broader market trends.
Despite the challenging price performance, the company maintains a market capitalisation grade of 3, indicating a mid-tier valuation within its industry group.
Financial Metrics and Operational Highlights
Entero Healthcare Solutions demonstrates a capacity to manage its financial obligations with a Debt to EBITDA ratio of 1.33 times, suggesting a moderate leverage position. This ratio indicates the company’s ability to service its debt from earnings before interest, taxes, depreciation, and amortisation.
Long-term growth indicators show that net sales have expanded at an annual rate of 30.10%, while operating profit has grown at a rate of 127.38%. The company has reported positive results for seven consecutive quarters, with the latest quarterly figures marking highs in several key areas: profit after tax (PAT) at Rs.31.60 crores, net sales at Rs.1,570.95 crores, and profit before depreciation, interest, and taxes (PBDIT) at Rs.62.06 crores.
Return on capital employed (ROCE) stands at 8.6%, accompanied by an enterprise value to capital employed ratio of 2.2, which suggests a valuation that is attractive relative to capital utilisation. The stock trades at a discount compared to the average historical valuations of its peers.
Over the past year, while the stock price has declined by 33.83%, the company’s profits have risen by 142%, resulting in a price/earnings to growth (PEG) ratio of 0.3. This divergence between earnings growth and stock price movement is notable in the current market context.
Institutional investors hold 24.32% of the company’s shares, reflecting a significant stake by entities with extensive resources and analytical capabilities.
Considering Entero Healthcare Solutions ? Wait! SwitchER has found potentially better options in Retailing and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Retailing + beyond scope
- - Top-rated alternatives ready
Summary of Current Situation
The stock of Entero Healthcare Solutions has reached an all-time low, reflecting a sustained period of price weakness that contrasts with the company’s underlying financial growth and profitability. The stock’s performance over multiple time frames shows consistent underperformance relative to the Sensex and sector benchmarks. Despite positive quarterly results and healthy sales growth, the market valuation has not aligned with these fundamentals.
The trading below all major moving averages and the recent 52-week low price point underscore the prevailing market sentiment. The company’s moderate leverage and institutional shareholding provide some stability, but the stock’s price trajectory remains subdued.
Investors and market participants observing Entero Healthcare Solutions will note the divergence between operational results and market valuation, which continues to shape the stock’s current position in the Retailing sector.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
